Pfizer Inc is > 10% Shareholder of SpringWorks Therapeutics, Inc.. Currently has a direct ownership of 4.59 Million shares of SWTX, which is worth approximately $181 Million. The most recent transaction as insider was on Sep 17, 2019, when has been sold 50,000 shares (Common Stock) at a price of $18.0 per share, resulting in proceeds of $900,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.59M
0% 3M change
0% 12M change
Total Value Held $181 Million

PFIZER INC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 17 2019
BUY
Open market or private purchase
$900,000 $18.0 p/Share
50,000 Added 1.08%
4,593,847 Common Stock
Sep 17 2019
BUY
Conversion of derivative security
-
4,543,847 Added 50.0%
4,543,847 Common Stock

Also insider at

VTRS
Viatris Inc Healthcare
CERE
Cerevel Therapeutics Holdings, Inc. Healthcare
ICUI
ICU MEDICAL INC Healthcare
ALLO
Allogene Therapeutics, Inc. Healthcare
BCAB
BioAtla, Inc. Healthcare
PYXS
Pyxis Oncology, Inc. Healthcare
CRTX
Cortexyme, Inc. Healthcare
IMRA
IMARA Inc. Healthcare
PI

Pfizer Inc

> 10% Shareholder
New York, NY

Track Institutional and Insider Activities on SWTX

Follow SpringWorks Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SWTX shares.

Notify only if

Insider Trading

Get notified when an Spring Works Therapeutics, Inc. insider buys or sells SWTX shares.

Notify only if

News

Receive news related to SpringWorks Therapeutics, Inc.

Track Activities on SWTX